Why Doctors Are Taking Over Venture Capital
with Dr. Vipul Kella, Dr. Paul Slosar & Dutch Rojas
Welcome to the PhyCap Podcast—where healthcare operators fund the future.
In this premiere episode, we ask the question too few are willing to confront:
What if physicians—not financiers—were the ones funding healthcare innovation?
Dr. Vipul Kella and Dr. Paul Slosar aren’t just your typical investors. They’re frontline clinicians, operators, and builders who’ve seen how traditional venture capital fails the very system it claims to fix.
They’ve traded scrubs for cap tables—but brought the clinical precision with them.
🎧 In This Episode:
Why most healthcare VCs don’t understand healthcare
What clinical relevance really looks like in a pitch
The red flags only physicians catch during diligence
How PhyCap is structured to support founders—before and after funding
Why now is the moment for doctors to become LPs
The “perfect startup” checklist from two medical insiders
What a win looks like for the fund—and the industry
Whether you’re a founder building in health tech, a physician tired of watching from the sidelines, or an LP ready to back real-world operators—this episode delivers.
Meet Your Hosts
Dr. Vipul Kella, MD MBA
Emergency physician, health system operator, and venture advisor with expertise in digital health, remote monitoring, and hospital innovation.
20 years clinical experience | Bethesda, MD & Washington, DC
Dr. Paul Slosar, MD MHCDS
Orthopedic spine surgeon turned multi-exit founder, CMO, and med-tech strategist. Specializes in product adoption, ASC growth, and early-stage scale.
29 years clinical experience | San Francisco, CA & Park City, UT
Ready to Join the Movement?
Pitch your startup to PhyCap → www.phycapfund.com
We want you as Limited Partner (LP). Email info@phycap.com to learn more.
Subscribe to this newsletter for weekly episodes and founder spotlights.
This is where healthcare gets rebuilt—by those who know it best.
🎙️ Listen now.
🔁 Share it with someone ready to invest with purpose.
📩 Drop a comment and tell us what you’d like to hear next.
